The FDA has granted accelerated approval to the combination of atezolizumab, an antibody marketed by Genentech under the name Tecentriq, and chemotherapy for certain patients with metastatic triple-negative breast cancer.

Addressing social determinants of health improves outcomes, possibly providing a return on investment. Margins matter, but it’s a long game, often driven by a sense of mission.

Receiving payments from industry influenced physicians’ device selection but not patient outcomes, according to researchers who analyzed three years of Open Payment Program data.

Even though the Hospital Readmission Reduction Program (HRRP) targeted principal heart failure admissions, a new analysis in the Journal of the American College of Cardiology showed readmissions also declined for patients with a secondary diagnosis of heart failure.

Researchers in Britain are calling for better, faster tests to distinguish between viral and bacterial illness in children presenting to emergency rooms with a fever. Such a development would save children and their families the anxiety of unnecessary exams, including imaging, and make a meaningful dent in the financial burden on the U.K’s National Health Service.

The courts typically side with defendant physicians when patients file medical malpractice lawsuits related to image-guided interventions, according to a new study published by the Journal of Vascular and Interventional Radiology.

Carestream Health announced Thursday, March 7, its plan to sell the company’s healthcare information systems (HCIS) business to Royal Philips.

The AI in medicine market generated $719 million in 2017 and could hit $18.12 billion by 2025, according to a new report from Big Market Research.